巨子 ICON - 財經股票資訊及專家分析
快訊
資訊
    虛擬市場
    搜尋 股票/指數/編號

    快訊

    資訊

    Arrowhead Pharmaceuticals

    ARWR
    34.490
    0.210
    0.60%
    最少15分鐘延遲,股票資訊由第三方資訊供應商提供
    ・Arrowhead Pharmaceuticals - 延遲價格・最後更新於 24/06 12:15
    最高位
    35.080
    最低位
    32.910
    開市價
    --
    前收市價
    34.285
    成交量(千)
    62.93
    成交額(百萬)
    19.33
    買入
    --
    賣出
    --
    每手股數
    --
    市值(百萬)
    3,646.84
    市盈率
    --
    息率
    --
    差價
    --
    52週高低
    91.000 - 26.810
    所有資料不保證絕對正確、完整、或實時,僅作為參考使用。投資涉及風險,過往業績並不代表將來表現,作任何投資決定或交易前,閣下應諮詢獨立專業意見。所有內容均不構成投資建議。

    企業資料

    公司名稱
    Arrowhead Pharmaceuticals
    證券代碼
    ARWR.US
    所屬板塊
    Biotechnology
    公司業務
    Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting hepatitis B, Alpha-1 Antitrypsin Deficiency, thrombosis and angioedema, clear-cell and renal cell carcinoma, and cardiovascular disease.
    發行量
    105736200
    公司總部
    177 E. Colorado Boulevard, Suite 700
    公司網址
    https://www.arrowheadpharma.com
    公司電郵
    ir@arrowheadpharma.com
    公司電話
    +1 626 304-3400
    暫無內容

    關於

    Arrowhead Pharmaceuticals(ARWR.US)所屬的行業板塊為Biotechnology。
    Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting hepatitis B, Alpha-1 Antitrypsin Deficiency, thrombosis and angioedema, clear-cell and renal cell carcinoma, and cardiovascular disease.
    詳細公司背景可參考: https://www.arrowheadpharma.com